This meeting took place in 2015


Here are the related meetings in 2020:
Cancer Epigenetics: New Mechanisms and Therapeutic Opportunities (J4)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Epigenetics and Cancer (A4)


Organizer(s) Tony Kouzarides and Kristian Helin
January 25—30, 2015
Keystone Resort • Keystone, Colorado USA
Discounted Abstract Deadline: Sep 30, 2014
Abstract Deadline: Oct 23, 2014
Scholarship Deadline: Sep 30, 2014
Discounted Registration Deadline: Nov 24, 2014

Sponsored by AstraZeneca, Bayer HealthCare Pharmaceuticals, Cell Research, Cell Signaling Technology, Inc., Constellation Pharmaceuticals and Incyte Corporation. Supported by an educational grant from Celgene Corporation.

Summary of Meeting:
Cancer epigenetics is a new and rapidly developing area of research. This results from the discovery that many epigenetic regulators (chromatin modifying enzymes, modification-reading proteins and chromatin-remodeling activities) are found mutated in cancers and has led to the recent approval of cancer drugs targeting epigenetic enzymes. The meeting aims to bring together scientists who are interested in understanding the connections between basic epigenetic pathways and the process of cancer. One aspect of the meeting will highlight the mechanisms by which epigenetic pathways control various biological processes. Information will be presented on chromatin and DNA modifications, chromatin complexes and ncRNAs. A second aspect will revolve around the connections between epigenetic pathways and cancer. This section will highlight genetic and epigenetic changes that take place during oncogenesis and efforts to counteract cancer with small molecule inhibitors against epigenetic regulators. The hope is to provide a forum for the interchange of information and know-how between the two converging fields of cancer research and epigenetics.

View Meeting Program

Scholarships/Awards

Early Career Investigator Travel Award Recipients
made possible by National Institute for General Medical Sciences (NIGMS) Ancillary Training Program Funding

Justina Dolorita McEvoy
University of Arizona, USA

Keystone Symposia Future of Science Fund Scholarship Recipients

Bernd Boidol
CeMM Research Center for Molecular Medicine GmbH, Austria

Hiroki Takai
Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan

National Cancer Institute (NCI) Scholarship Recipients

Pier-Luc Clermont
BC Cancer Research Centre, Canada

Stephen C. Mack
Baylor College of Medicine, USA

The Elkes Foundation Scholarship Recipients

Albert J. Keung
Boston University, USA

Lindsay M. LaFave
Koch Institute for Integrative Cancer Research at MIT, USA

Rachelle R. Olsen
St. Jude Children's Research Hospital, USA